title: Plasma-derived versus recombinant hepatitis B vaccines.
authors.forename: J B
authors.initials: JB
authors.lastname: Kurtz
authors.forename: M J
authors.initials: MJ
authors.lastname: Alder
authors.forename: R T
authors.initials: RT
authors.lastname: Mayon-White
authors.forename: B E
authors.initials: BE
authors.lastname: Juel-Jensen
authors.forename: T M
authors.initials: TM
authors.lastname: Rodgers
authors.forename: G M
authors.initials: GM
authors.lastname: Babic
mesh_terms: D002986:Clinical Trials as Topic; D005260:Female; D006509:Hepatitis B / Q000276:immunology*; D006510:Hepatitis B Antibodies / Q000032:analysis; D017325:Hepatitis B Vaccines; D006801:Humans; D007115:Immunization Schedule; D008297:Male; D011897:Random Allocation; D014612:Vaccines / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000276:immunology*; D014761:Viral Hepatitis Vaccines / Q000276:immunology*
chemical_list: D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines; D014612:Vaccines; D014614:Vaccines, Synthetic; D014761:Viral Hepatitis Vaccines